Established in 2006, VHIO is a leading comprehensive cancer center of excellence where its researchers and physician-scientists adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer.
Undertaking one of Spain´s most dynamic cancer research programs and recognized as a leading reference in drug discovery from concept to the clinic (phase I-II clinical trials), VHIO is dedicated to delivering on the promise of ´precision´medicine in oncology – turning cancer discovery into more effective treatments and better practice for the care of patients.
ICREA is a foundation supported by the Catalan Government established to strengthen the research system in Catalunya, recruiting and retaining top researchers in the Catalan R&D system. They have an excellent track record in technology transfer and lab-to-market initiatives in general.
HealthEquity is a Spanish venture capital firm investing in early-stage companies in the healthcare sector, with a special focus on biotechnology and medical devices. Founded by the Barcelona Medical Association and the financial group Riva y Garcia, HealthEquity is looking for projects to bring successful innovative life science companies to the marketplace and to foster the Catalan and Spanish biotech ecosystem.
This company is capitalized by Innvierte, an investment program of CDTI, E.P.E.
AurorA Science is a biotech investment company integrating an innovative financial and industrial approach in the research and development challenge. The company is focused on independent and entrepreneurial biotech start-ups in Europe with high therapeutic potential, providing industrial and financial support.
Asabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation. Asabys acts as investment advisor to the fund ALSS I.
The Institut Català de Finances (ICF) is the Government of Catalonia’s public development bank. Through its venture capital activity, the ICF works to strengthen Catalonia’s business and financial ecosystem, mobilize private investment and back projects with transformative potential and strong local roots. It acts as an institutional investor and as a catalyst for the ecosystem, helping consolidate fund management companies, facilitating public-private co-investment and making capital available at every stage of growth, from knowledge transfer to the expansion of established companies.
Established in 2020, the EIC Fund is the Venture Capital investment arm of the European Innovation Council (EIC). With a capitalisation of over €4 billion, it bridges the gap between public and private financing, supporting Europe’s most promising startups and scaleups.